We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQ icon
901
Arq
ARQ
$89.3M
$529K 0.02%
+71,380
New +$440K
SNAP icon
902
Snap
SNAP
$9.01B
$528K 0.02%
+7,753
New +$465K
LYFT icon
903
PUT
Lyft
LYFT
$6.63B
$526K 0.02%
8,700
-57,400
-87% -$3.3M
IONQ icon
904
IonQ
IONQ
$16.6B
$525K 0.02%
+49,090
New +$508K
MSFT icon
905
PUT
Microsoft
MSFT
$3.71T
$524K 0.02%
2,300
-1,100
-32% -$280K
AVY icon
906
Avery Dennison
AVY
$13.4B
$523K 0.02%
+2,487
New +$522K
XOG
907
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$523K 0.02%
9,525
-48,445
-84% -$2.29M
VISN
908
Vistance Networks Inc
VISN
$2.52B
$522K 0.02%
24,516
+7,946
+48% +$148K
GNK icon
909
Genco Shipping & Trading
GNK
$1.1B
$521K 0.02%
27,611
-37,889
-58% -$586K
ARVN icon
910
Arvinas
ARVN
$572M
$520K 0.02%
6,750
+600
+10% +$41.7K
SNPS icon
911
Synopsys
SNPS
$79.7B
$520K 0.02%
1,886
+663
+54% +$168K
MLTX icon
912
MoonLake Immunotherapeutics
MLTX
$1.55B
$518K 0.02%
+50,000
New +$508K
LUMN icon
913
Lumen
LUMN
$6.44B
$517K 0.02%
38,026
+16,726
+79% +$231K
XEL icon
914
Xcel Energy
XEL
$48.8B
$516K 0.02%
7,496
+2,233
+42% +$155K
TQQQ icon
915
CALL
ProShares UltraPro QQQ
TQQQ
$37.4B
$515K 0.02%
16,800
-9,200
-35% -$243K
NLSN
916
DELISTED
Nielsen Holdings plc
NLSN
$515K 0.02%
20,864
+837
+4% +$21.9K
EL icon
917
Estee Lauder
EL
$32B
$514K 0.02%
+1,616
New +$490K
GOLD
918
Gold.com Inc
GOLD
$1.26B
$513K 0.02%
22,070
-8,688
-28% -$194K
COLD icon
919
Americold
COLD
$4.27B
$512K 0.02%
+13,446
New +$521K
PETS icon
920
PUT
PetMed Express
PETS
$42.3M
$510K 0.02%
16,000
MACQ
921
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
$509K 0.02%
+52,875
New +$513K
BMI icon
922
Badger Meter
BMI
$4.03B
$507K 0.02%
+5,164
New +$488K
FATE icon
923
Fate Therapeutics
FATE
$326M
$507K 0.02%
5,837
+1,700
+41% +$137K
NSC icon
924
Norfolk Southern
NSC
$75.1B
$507K 0.02%
+1,911
New +$527K
HTGC icon
925
Hercules Capital
HTGC
$3.23B
$505K 0.02%
29,575
-2,925
-9% -$50K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.